BRWA
ZYNE

B. Riley Wealth Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

B. Riley Wealth Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,732
Closed -$16.2K – 1643
2024
Q1 		$16.2K Buy
+12,732
New +$16.2K ﹤0.01% 1431
2023
Q4 		– Sell
-12,732
Closed -$16.2K – 1531
2023
Q3 		$16.2K Buy
+12,732
New +$16.2K ﹤0.01% 1431